Breast Cancer

, Volume 16, Issue 3, pp 202–206 | Cite as

A new reporting form for breast cytology

  • Shin-ichi Tsuchiya
  • Futoshi Akiyama
  • Takuya Moriya
  • Hitoshi Tsuda
  • Shinobu Umemura
  • Yousei Katayama
  • Akinori Ishihara
  • Yasuteru Inai
  • Hitoshi Itoh
  • Takashi Kitamura
Special Feature Current issues and perspectives on breast cancer diagnosis

Abstract

The Cytology and Core Needle Biopsy Subcommittee, organized under the Rules Committee of the Japanese Breast Cancer Society, has prepared a new form for breast cytology reports. This reporting form consists of “diagnostic categories” and “recommendations.” The “diagnostic category” is either “specimen inadequacy” or “specimen adequacy.” The judgment on “specimen adequacy” is subdivided into four categories: “normal or benign,” “indeterminate,” “suspicious for malignancy,” and “malignant.” The “recommendation” indicates descriptions of cytological features and estimated histological type of tumor (these descriptions should be as detailed as possible). On the basis of an analysis of cytological data from 3,439 cases performed before preparing this form, the subcommittee has attached the following recommended goals to this form: (1) the percentage of “specimen inadequacy” should be 10% or less of all samples, (2) the percentage of “indeterminate” samples should be 10% or less of all “specimen adequacy” cases, and (3) 90% or more of “suspicious for malignancy” cases should be diagnosed as “malignant” in a subsequent histological examination. We hope that modification of this form, if it requires revision in the future, will be evidence-based, as was the process for compiling this set of rules.

Keywords

Breast Fine-needle aspiration cytology New reporting form 

References

  1. 1.
    Cytology Sub-Group of the National Coordinating Committee for Breast Screening Pathology Guidelines for cytology procedures and reporting in breast cancer screening. Sheffield: National Health Service Breast Screening Programme Publications; 1993.Google Scholar
  2. 2.
    Bibbo M, Abati A, for the NCI Breast FNA Conference. The uniform approach to the breast fine needle aspiration biopsy. Asynopsis Acta Cytol. 1996;40:1120–6.Google Scholar
  3. 3.
    Page DL, Hohnson JE, Dupont WD. Probabilistic approach to the reporting of fine-needle aspiration of the breast. Cancer Cytopathol. 1997;81:6–9.Google Scholar
  4. 4.
    Chew I, Tan Y, Tan PH. Cytology is useful in breast screening: results and long-term follow-up of the Singapore Breast Screening Pilot Project. Cytopathology. 2006;17:227–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Japanese Breast Cancer Society. General rules for clinical and pathological recording of breast cancer. Breast Cancer. 2005;12:10–1.CrossRefGoogle Scholar
  6. 6.
    Solomon D, Nayar R. The Bethesda System for reporting cervical cytology, definitions, criteria, and explanatory notes. 2nd ed. New York: Springer; 2004.Google Scholar
  7. 7.
    Sneige N. Should specimen adequacy be determined by the opinion of the aspirator or by the cells on the slides? Cancer Cytopathol. 1997;81:3–5.Google Scholar
  8. 8.
    The Japanese Society of Thyroid Surgery. General rules for the description of thyroid cancer (in Japanese). 6th ed. Shuppan: Kanehara; 2006.Google Scholar

Copyright information

© The Japanese Breast Cancer Society 2009

Authors and Affiliations

  • Shin-ichi Tsuchiya
    • 1
    • 2
  • Futoshi Akiyama
    • 1
  • Takuya Moriya
    • 1
  • Hitoshi Tsuda
    • 1
  • Shinobu Umemura
    • 1
  • Yousei Katayama
    • 1
  • Akinori Ishihara
    • 1
  • Yasuteru Inai
    • 1
  • Hitoshi Itoh
    • 1
  • Takashi Kitamura
    • 1
  1. 1.Cytology and Core Needle Biopsy Subcommittee of the Japanese Breast Cancer SocietyTokyoJapan
  2. 2.Division of Diagnostic PathologyNippon Medical School HospitalTokyoJapan

Personalised recommendations